Detalhe da pesquisa
1.
A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine as Adjuvant to Opioids in Terminally Ill Cancer Patients With Refractory Cancer Pain (CIVIK Trial).
Am J Hosp Palliat Care
; : 10499091241252977, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752431